Fortuna A.
24
Coauthors
4
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 2 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Farmacología | 2 |
| Neurología | 2 |
| Medicamento | 2 |
| Bioquímica | 1 |
| Salud mental | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Farmacología y terapéutica | 4 |
| Enfermedades | 3 |
| Medicina y salud | 2 |
| Bioquímica | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 4 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Falcao A.C. | 3 |
| Alves G. | 2 |
| Adrián LLerena | 2 |
| Magalhães P. | 2 |
| Antoni Camins | 2 |
| Ettcheto M. | 2 |
| Verdaguer E. | 1 |
| Bulló M. | 1 |
| Sanchez-Lopez E. | 1 |
| Cano A. | 1 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Pharmacogenetics and therapeutic drug monitoring of fluoxetine in a real-world setting: A PK/PD analysis of the influence of (Non-)genetic factors
ArticleAbstract: This work presents the GnG-PK/PD-AD study-a pharmacokinetics/pharmacodynamics (PK/PD) analysis of thPalabras claves:Biomarkers, Fluoxetine, pharmacogenetics, Real-world data, Therapeutic drug monitoringAutores:Adrián LLerena, Alves G., Falcao A.C., Fortuna A., Magalhães P.Fuentes:scopusReal-World Clinical Characterization of Subjects With Depression Treated With Antidepressant Drugs Focused on (Non-)Genetic Factors, Pharmacokinetics, and Clinical Outcomes: GnG-PK/PD-AD Study
ArticleAbstract: This work aimed to describe and characterize the GnG-PK/PD-AD study and the population of subjects dPalabras claves:antidepressants, Cytochrome p450, P-Glycoprotein, pharmacogenetics, Real-world settingAutores:Adrián LLerena, Alves G., Falcao A.C., Fortuna A., Magalhães P.Fuentes:scopusTargeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: Past, present and future
ReviewAbstract: Alzheimer's disease (AD) is a well-known neurodegenerative disease characterized by the presence ofPalabras claves:Alzheimer's disease, Angiotensin, Angiotensin converting enzyme, Angiotensin II receptor blockers, Renin-angiotensin systemAutores:Antoni Camins, Bicker J., Cruz M.T., Ettcheto M., Falcao A.C., Fortuna A., Gouveia F.Fuentes:scopusProtein tyrosine phosphatase 1B (PTP1B) as a potential therapeutic target for neurological disorders
ReviewAbstract: Protein tyrosine phosphatase 1B (PTP1B) is a typical member of the PTP family, considered a direct nPalabras claves:Alzheimer's disease, insulin receptor, neurodegenerative diseases, neuroinflammation, Neurological disorders, PTP1B, Type 2 DiabetesAutores:Antoni Camins, Auladell C., Bulló M., Cano A., Carrasco M., Ettcheto M., Folch J., Fortuna A., Olloquequi J., Sanchez-Lopez E., Verdaguer E.Fuentes:scopus